New Review on #CancerVaccines: John Haanen and colleagues highlight insights from recent clinical trials and discuss critical factors for optimization, with a focus on proxies for efficacy, #neoantigen selection, modular platforms and early intervention
www.nature.com/articles/s41...
This Review highlights insights from recent clinical trials and discusses critical factors for optimizing cancer vaccines, with a focus on proxies for vaccine efficacy, neoantigen selection, modular p...
